Skip to content
SHM Abstracts | Society of Hospital Medicine Logo
  • Home
  • Meetings Archive
  • Browse By Category
  • Browse By Keyword
  • Search
  • Home
  • Meetings Archive
  • Browse By Category
  • Browse By Keyword
  • Search
  • Home
  • Meetings Archive
  • Browse By Category
  • Browse By Keyword
  • Search
  • Home
  • Meetings Archive
  • Browse By Category
  • Browse By Keyword
  • Search
Search2020-05-20T12:01:36-05:00
Search
Search by Abstract Number, Title, Keyword, or Authors
Category
Sub-Category

(Optional)

Session Type
Meeting
Search Results for withdrawal
Abstract Number: 44
PHENOBARBITAL VS. SYMPTOM TRIGGERED LORAZEPAM FOR ALCOHOL WITHDRAWAL ON GENMED
SHM Converge 2023
Background: Alcohol withdrawal is a common issue in hospitalized patients and is associated with significant morbidity and mortality. Alcohol withdrawal occurs when the gamma aminobutyric acid (GABA) stimulating effect of alcohol is removed, resulting in an excess of the excitatory neurotransmitter glutamate. Treatment typically consists of as needed benzodiazepines, which activate GABA. However, this reactive […]
Abstract Number: 156
CLINICAL CHARACTERISTICS AND OUTCOMES OF VETERANS HOSPITALIZED WITH ALCOHOL WITHDRAWAL
SHM Converge 2023
Background: Although alcohol withdrawal (AW) is common in hospitalized patients, few studies describe contemporary alcohol withdrawal management in hospitalized settings or compare practices to recent guidelines published by the American Society of Addiction Medicine (ASAM). We sought to describe patient characteristics and determine factors associated with complicated withdrawal and treatment duration in hospitalized patients with […]
Abstract Number: 243
PHENOBARBITAL MONOTHERAPY FOR ALCOHOL WITHDRAWAL SYNDROME: IMPLEMENTATION AND OUTCOMES
SHM Converge 2023
Background: Phenobarbital (PB) has important pharmacological advantages over benzodiazepines (BZDs) for treatment of alcohol withdrawal syndrome (AWS). The American Society of Addiction Medicine recommends PB monotherapy as an alternative to BZDs for prophylaxis or treatment of AWS by providers experienced with its use. Few studies have described the use of PB for AWS outside of […]
Abstract Number: 358
INTERDISCIPLINARY COLLABORATION TO IMPROVE INPATIENT TREATMENT OF OPIOID USE DISORDER
SHM Converge 2023
Background: The incidence of Opioid Use Disorder (OUD) is rising around the world with nearly 27 million people living with OUD globally and over 100,000 opioid overdose deaths each year. The Society of Hospital Medicine recently released a consensus statement for management of patients with OUD admitted to the hospital. This statement included recommendations for […]
Abstract Number: 368
IMPROVED TREATMENT PROTOCOL FOR ALCOHOL WITHDRAWAL SYNDROME
SHM Converge 2023
Background: Approximately 5% of patients hospitalized at our institution develop clinically significant alcohol withdrawal syndrome (AWS). Inpatients who develop AWS may experience seizures, delirium, ICU transfer and prolonged length of stay. While the mortality of AWS, mostly related to delirium tremens, has decreased over time, severe alcohol withdrawal is still associated with a mortality of […]
Abstract Number: 848
WHEN TOXIDROMES COLLIDE
SHM Converge 2023
Case Presentation: A 43-year-old woman with general anxiety disorder and benzodiazepine abuse was brought to the emergency department by her husband with nausea, diarrhea, agitation, and altered mental status. She also endorsed restlessness and muscle tension. Examination revealed an agitated, disoriented woman with three days of amnesia. Vitals signs were within normal limits. Drug and […]
  • This Week

  • This Month

  • All Time

  • This Week

  • A CASE OF SKIN NECROSIS CAUSED BY INTRAVENOUS XYLAZINE ABUSE
  • A Patient’s Presentation of Persistent Sweet Taste in Her Mouth Leads to a Diagnosis of Small Cell Lung Cancer
  • RECOGNIZING S1Q3T3 FOR WHAT IT IS: A NONSPECIFIC PATTERN OF RIGHT HEART STRAIN
  • Bc Powder Causing Intracerebral Bleed: Pitfalls of Overlooking Dosage of Seemingly Innocuous Otc Formulations
  • ADDERALL INDUCED ISCHEMIC COLITIS
  • This Month

  • A CASE OF SKIN NECROSIS CAUSED BY INTRAVENOUS XYLAZINE ABUSE
  • REMDESIVIR REDUCES MORTALITY IN HOSPITALIZED COVID-19 PATIENTS REQUIRING LOW-FLOW OXYGEN
  • RECOGNIZING S1Q3T3 FOR WHAT IT IS: A NONSPECIFIC PATTERN OF RIGHT HEART STRAIN
  • A Patient’s Presentation of Persistent Sweet Taste in Her Mouth Leads to a Diagnosis of Small Cell Lung Cancer
  • ADDERALL INDUCED ISCHEMIC COLITIS
  • All Time

  • ADDERALL INDUCED ISCHEMIC COLITIS
  • Bc Powder Causing Intracerebral Bleed: Pitfalls of Overlooking Dosage of Seemingly Innocuous Otc Formulations
  • PECULIAR PRESENTATION OF VERTIGO IN HYPOTHYROIDISM
  • A CASE OF SKIN NECROSIS CAUSED BY INTRAVENOUS XYLAZINE ABUSE
  • RECOGNIZING S1Q3T3 FOR WHAT IT IS: A NONSPECIFIC PATTERN OF RIGHT HEART STRAIN
© Society of Hospital Medicine | All Rights Reserved
Page load link
Go to Top